Comorbidities treated in primary care in children with chronic fatigue syndrome / myalgic encephalomyelitis: A nationwide registry linkage study from Norway. — CFSMEATLAS
Comorbidities treated in primary care in children with chronic fatigue syndrome / myalgic encephalomyelitis: A nationwide registry linkage study from Norway.
Bakken, Inger J, Tveito, Kari, Aaberg, Kari M et al. · BMC family practice · 2016 · DOI
Quick Summary
This large Norwegian study looked at health problems that children with ME/CFS commonly experience in primary care compared to other children. Children with ME/CFS were much more likely to have records of extreme tiredness, depression, anxiety, migraines, and muscle pain. Interestingly, many children with ME/CFS had a recent infection (especially infectious mononucleosis) before their diagnosis, suggesting infections might play a role in developing the condition.
Why It Matters
This study provides robust epidemiological evidence that infections—particularly infectious mononucleosis—may be involved in ME/CFS development, supporting an important research hypothesis. The finding that nearly half of children experience significant diagnostic delays highlights gaps in clinical recognition and emphasizes the need for better awareness among primary care providers.
Observed Findings
89.9% of children with CFS/ME had primary care diagnoses of weakness/general tiredness versus 14.5% with T1DM and 11.1% of general population.
11.1% of children with CFS/ME had documented infectious mononucleosis in the 2 years prior to diagnosis, compared to 0.5% in the T1DM group.
Depressive disorder and anxiety disorder diagnoses were significantly more common in the CFS/ME group than comparison groups.
74.6% of children with CFS/ME had a prior primary care diagnosis of weakness/tiredness recorded before their specialist CFS/ME diagnosis.
47.8% of children experienced a time lag of 1 year or longer between first weakness/tiredness diagnosis and specialist CFS/ME diagnosis.
Inferred Conclusions
Infections may be involved in the causal pathway to CFS/ME in children, based on the elevated prevalence of documented infections prior to diagnosis.
Clinical presentation of CFS/ME is complex and multifaceted, encompassing infectious, neurological, and psychiatric comorbidities.
Diagnostic delays are common in CFS/ME, suggesting suboptimal treatment pathways and potential need for improved clinical recognition in primary care.
Remaining Questions
Does prior infection directly cause CFS/ME in susceptible individuals, or are both related to an underlying vulnerability factor?
What This Study Does Not Prove
This study does not establish that infections cause ME/CFS—only that they occur more frequently before diagnosis, which could reflect surveillance bias or shared risk factors. It cannot determine whether depression and anxiety are primary features, consequences of chronic illness, or partially artifacts of increased healthcare contact. Registry data also may not capture all symptoms or diagnoses, and results are limited to Norwegian children.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Phenotype:Infection-TriggeredPediatric
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
What proportion of children with recent infections develop CFS/ME versus other outcomes, and what factors determine this progression?
Would earlier specialist referral following initial weakness/tiredness diagnosis improve patient outcomes or merely advance timing of diagnosis?
How do psychiatric comorbidities (depression, anxiety) in the CFS/ME group relate temporally to fatigue onset—are they primary, secondary, or concurrent manifestations?